|
Home | Issues | eMJA shop | Classifieds | Contact | More... | Topics | Search | Login | Buy full access |
Robert G Moses and Stephen Colagiuri
→ Other articles have cited this article
Abstract - Introduction - Methods - Validation of the NSW Midwives Data Collection - Results - Discussion - References - Authors' details
Register to be notified of new articles by e-mail -
Current contents list -
©MJA1997
Following the Australasian Diabetes in Pregnancy Society's (ADIPS)
1991 recommendation that all pregnant women should be tested for GDM
in every pregnancy,5 the NSW
Midwives Data Collection (MDC) recorded a gradual increase in the
number of women with GDM from 1.5% in 1991 to 2.7% in 1994. In contrast,
from surveys in other Australian centres since 1991, the incidence of
GDM ranges from 5.5%-8.8%.4,6-8
The difference between these rates and those recorded by the MDC
suggests that many women are still not being tested for GDM in NSW and
are at risk of complications which could either be prevented or
substantially reduced. The purpose of our study was to estimate the
extent of undiagnosed GDM in NSW for the period 1991-1994 by
estimating the number of pregnant women who had not been tested for
GDM.
Incidence of GDM recorded on the MDC was compared with the incidence of
GDM found in three different Australian surveys. The sources of these
data are shown in Box 1. The three surveys used the 75 g oral glucose
tolerance test for the diagnosis of GDM based on the ADIPS criteria.5 According to these
criteria, GDM is diagnosed if the fasting plasma glucose level is
At the Mercy Hospital for Women in Melbourne, a 50 g glucose load is
used and capillary blood samples taken for plasma glucose
measurement; a diagnosis of GDM is made if the glucose level at one hour
is
While the incidence of GDM will vary depending on the ethnic
composition of the population being examined, these surveys all
included a majority of people of European extraction.
A 1993 survey carried out in the Wollongong area to determine the
incidence of GDM was compared with the recorded MDC incidence of GDM in
the area.6 The MDC recorded a
rate of 5.0%, while the survey found a rate of 7.2%. A 50% addition to the
recorded MDC incidence (as indicated by the validation study) gave a
figure of 7.5%, which is similar to the 7.2% found in the survey.
Therefore, the addition of a 50% correction factor to the recorded MDC
incidence of GDM is a reasonable approximation.
For the whole of NSW, the percentage of women diagnosed with GDM
increased from 1.5% in 1991 to 1.9% in 1992 (P < 0.001) and
from 1.9% in 1992 to 2.6% in 1993 (P < 0.001). There was no
significant change between 1993 and 1994. For the four-year period,
the overall recorded MDC incidence of GDM was 2.2%.
In the Sydney metropolitan area, the incidence of GDM ranged from a
high of 3.1% in the Central Sydney Area Health Service to a low of 1.5% in
the Northern Sydney Area Health Service. The incidence of GDM in the
main metropolitan areas of Sydney, Newcastle and Wollongong was
2.4%, which was significantly higher than the country areas (1.6%) (P < 0.001). Some country areas also showed marked changes
over the four-year period. For example, the proportion of women
diagnosed with GDM increased from 0.8% to 2.7% in the Mid West Area
Health Service and declined from 3.4% to 0.8% in the Far West Area
Health Service.
By applying the 50% correction factor to the recorded MDC incidence of
2.2%, the estimated incidence of GDM is 3.3%. However, the
expected incidence of GDM is 6.6% (Box 1). Therefore, half of the
pregnant women in NSW during the period 1991-1994, or 173 534 women,
were probably not tested for GDM.
The recorded MDC incidence of GDM for 1991-1994 was lower than the
expected incidence. With the application of the 50% correction
factor to the recorded MDC incidence (as suggested by the MDC
validation study and by data collection in the Wollongong area6 ) and a conservative estimate for
the expected incidence of GDM, it is possible that half of all
the women who delivered in NSW between 1991 and 1994 were not tested for
GDM.
Some women may have decided not to be tested for GDM. Others may not have
been able to tolerate the glucose solution. In most cases, however,
the decision not to test would have undoubtedly been made by the
clinician responsible.
Box 2 shows that testing for GDM is not evenly distributed, with a
recorded MDC incidence range of 0.7%-3.2%. Of particular concern is
that lower than average rates of testing were found in areas where a
higher than average rate of GDM could be anticipated. In metropolitan
Sydney, the lowest number of recorded cases of GDM were from the
Northern Sydney Area Health Service. The MDC has shown that this is
also the Area Health Service with the highest proportion of women aged
35 years or over at the time of delivery, a risk factor for GDM. An
incidence of GDM of at least 10%4
could be anticipated in this age group.
Women with an Aboriginal background have a high incidence of GDM.8 The New England and
Macquarie Area Health Service, with a high proportion of Aboriginal
Australians, had a rate of GDM less than the non-metropolitan
average. The Far West Area Health Service also has a high proportion of
Aboriginal Australians, and the recorded incidence of GDM there fell
over the four-year period from 3.4% to 0.8%.
Observational studies of women with untreated GDM have found a higher
perinatal mortality rate than that found in glucose-tolerant women.2,3 At the Mercy Hospital for
Women in Melbourne, Beischer et al. showed that, despite a steady
reduction in the overall perinatal mortality rate, women who were not
tested for GDM (and therefore not treated) had a significantly higher
perinatal mortality rate than women who were tested.4 An estimate can be made of the excess
perinatal mortality rate for women in NSW who have not been tested for
GDM ( Box 3).
Although the recorded incidence of GDM has increased (particularly
in the two years after the ADIPS recommendation for universal testing
was made), our results confirmed our belief that not all pregnant
women in NSW are being tested for GDM. This may have implications for
perinatal mortality rates.
Prince of Wales Hospital, Sydney, NSW.
No reprints will be available from the author. Correspondence: Dr R G Moses, 4/393
Crown Street, Wollongong, NSW, 2500.
Home
|
Issues
|
eMJA shop
| Terms of use
|
Classifieds
|
More...
|
Contact
|
Topics
|
Search
©MJA 1997
<URL: http://www.mja.com.au/>
© 1997 Medical Journal of Australia.
Abstract
Objectives: To estimate the number of pregnant women
in New South Wales who had not been tested for gestational diabetes
mellitus (GDM) during the period 1991-1994.
Design: The number of women not tested for GDM was
estimated from the recorded data available in the NSW Midwives Data
Collection (MDC) annual reports and compared with three incidence
surveys.
Main outcome measure: The number of pregnant women
not tested for GDM.
Results: Over the four-year period, the average
annual recorded MDC incidence of GDM was 2.2%. This percentage was
adjusted up to 3.3% after review of the MDC validation study and an
incidence study. However, the expected incidence of GDM from three
incidence surveys was 6.6%. Thus, half of the pregnant women in NSW do
not appear to have been tested for GDM.
Conclusion: For the four-year period 1991-1994, an
estimated 50% of women in NSW were probably not tested for GDM.
Introduction
Gestational diabetes mellitus (GDM) is carbohydrate intolerance of
variable severity with onset or first recognition during the current
pregnancy.1 Undiagnosed,
and therefore untreated, diabetes is a serious disorder of pregnancy
with an increased perinatal mortality rate.2,3,4
Methods
We obtained data from the NSW MDC annual reports for 1991-1994. It is a
statutory requirement under the Public Health Act 1991 (NSW)
that all births (including home births) are reported to the MDC, which
records information on maternal medical and obstetric conditions,
delivery and infant characteristics.
5.5 mmol/L and/or the two-hour plasma glucose level is
8.0 mmol/L. By combining these data, we obtain an average
incidence of GDM, which we refer to as the expected incidence.

9.0 mmol/L and the glucose level at two hours is
7.0 mmol/L. The incidence of GDM during the period
1991-1994 was 8.8%.4 While
the glucose load and diagnostic criteria are different, a comparison
of the Mercy Hospital and ADIPS criteria found that they diagnosed
similar women and in the same proportion.9
Validation of the NSW Midwives Data Collection
A 1990 validation study of the MDC, using a 1% sample, found that the
recording of data relating to GDM had a sensitivity of 66.7% and a
specificity of 99.6%.10
That is, when a case of GDM was recorded it was accurate, but only
two-thirds of the known cases were recorded. Therefore, by
increasing the recorded MDC incidence by 50% (representing the
underestimation of GDM according to the sensitivity data),
we are likely to obtain the actual MDC incidence, which we refer to as
the estimated incidence.
Results
The proportion of women with a diagnosis of GDM recorded by the MDC for
each different Area Health Service in NSW between 1991 and 1994 is
shown in Box 2. It was assumed that the accuracy of data recording in all
Area Health Services was equal and had not changed over the four-year
period.

Discussion
The expected incidence of GDM was derived from pooled
incidence data from the three surveys where the diagnosis had been
based on the ADIPS criteria. The lowest incidence was reported in the
two surveys which used data gathered from prenatal clinics.7,8 A higher incidence was reported in
the survey which included private patients in the data collection.6 The higher rate found in the
survey which included private patients could be anticipated, as
private patients are older than clinic patients and increasing age is
a high risk factor for developing GDM.4 Thus, the expected incidence
of GDM of 6.6% is likely to be conservative.
References
(Received 15 Jan, accepted 8 May, 1997)
Authors' details
Illawarra Area Health Service, NSW.
Robert G Moses, FRACP, Clinical Director of Diabetes
Services.
Stephen Colagiuri, FRACP, Director of Diabetes Services.
E-mail: r.moses @ uow.edu.au
Other articles have cited this article:
Christine A Stone, Kylie A McLachlan, Jane L Halliday, Peter Wein and Christine Tippett. Gestational diabetes in Victoria in 1996: incidence,
risk factors and outcomes Med J Aust 2002; 177 (9): 486-491. [Research] <http://www.mja.com.au/public/issues/177_09_041102/sto10788_fm.html>
Robert G Moses, Alison J Webb and Christine D Comber. Gestational diabetes mellitus: accuracy of Midwives Data Collection Med J Aust 2003; 179 (4): 218-219. [Letters] <http://www.mja.com.au/public/issues/179_04_180803/letters_180803_fm-2.html>
David Simmons, Barry N J Walters, Janet A Rowan and H David McIntyre. Metformin therapy and diabetes in pregnancy Med J Aust 2004; 180 (9): 462-464. [Clinical Update] <http://www.mja.com.au/public/issues/180_09_030504/sim10814_fm.html>
Leonie K Callaway, Johannes B Prins, Allan M Chang and H David McIntyre. The prevalence and impact of overweight and obesity in an Australian obstetric population Med J Aust 2006; 184 (2): 56-59. [Research] <http://www.mja.com.au/public/issues/184_02_160106/cal10167_fm.html>